Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP)

Published on :

Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP) Dr. Ginny Espina is a Research Associate Professor at George Mason University’s Center for Applied Proteomics and Molecular Medicine. She will be the Workshop Director for the upcoming Bio-TracⓇ Symposium, “Laser Microdissection: From Biology to Immuno-Oncology” that runs from March 4-8, 2019. ______ The BioBuzz team had the [….]

Q&A with Joseph Bressler, Ph.D.

Published on :

Q&A with Joseph Bressler, Ph.D., Research Scientist at Kennedy Krieger Institute January 29, 2019 Dr. Joseph Bressler is a research scientist at Kennedy Krieger Institute. He is also an associate professor of environmental health sciences at the Bloomberg School of Public Health at Johns Hopkins University. His research focuses on delineating responses to environmental agents [….]

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

Published on :

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by Medimmune & PerkinElmer (now Akoya Biosciences). After a successful first annual Symposium and Workshop, we had the opportunity to catch up with Course Director, Dr. [….]

Q&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1)

Published on :

Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech deals, especially in the immunotherapy market.  One deal, in particular, has generated more local excitement in the BioHealth Capital Region than any other; that is [….]

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology

Published on :

Abhita Batra, Otomagnetics CEO, Aims to Change the Lives of Childhood Cancer Survivors with Magnetic Drug Delivery Technology October 8, 2018 Abhita Batra, CEO Otomagnetics, Inc., is leading the growth of an innovative biotech startup, and bringing a drug delivery technology to market that could change the lives of childhood cancer survivors.  As with many [….]

Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy

Published on :

Q&A with Immunomic’s Teri Heiland, PhD What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy September 25, 2018   Teri Heiland, Ph.D. is the Senior Vice President of Research and Development, and Co-founder, at Immunomic Therapeutics, Inc., a clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. [….]

“In Conversation” with Mina Izadjoo, President of IPS

Published on :

“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one of the panelists, President and CSO of Integrated Pharma Services (IPS), Dr. Mina Izadjoo for a preliminary “In Conversation” interview. What is your background and [….]

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Carol Nacy, Ph.D.
Published on :

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance  For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all started with a fascination for things unseen. “At Catholic University a few wonderful biology professors introduced me to this amazing world of invisible life that [….]

Aaron Chang, Renalert CEO – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury

Published on :

In Conversation with Aaron Chang, CEO of Renalert – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury Every entrepreneur has a “founder’s story” that serves to build the unique framework for why they are just the right person to solve a specific problem. For Aaron Chang, CEO of Renalert, that story began at Johns [….]

Janice Riley, Manager of the TIC

Published on :

InConversation with Janice Riley, Manager of the TIC In recent years there has been a surge of interest in biotech entrepreneurship, with many scientists wanting to take their innovative ideas and develop them into new products and technologies.  And what better place to start a business than the up-and-coming BioHealth Capital Region!  Entrepreneurship comes with [….]